ABSTRACT. Large number of cellular changes and diseases are related to mutations in the mitochondrial DNA copy number. Cell culture in the presence of ethidium bromide is a known way of depleting mitochondrial DNA and is a useful model for studying such conditions. Interestingly, the morphology of these depleted cells resembles that of pluripotent cells, as they present larger and fragmented mitochondria with poorly developed cristae. Herein, we aimed to study the mechanisms responsible for the control of mitochondrial DNA replication during mitochondrial DNA depletion mediated by ethidium bromide and during the in vitro induction of cellular pluripotency with exogenous transcription factor expression in a bovine model. This article reports the generation of a bovine Rho0 mesenchymal cell line and describes the analysis of mitochondrial DNA (2015) copy number in a time-dependent manner. The expression of apoptosis and mitochondrial-related genes in the cells during mitochondrial DNA repletion were also analyzed. The dynamics of mitochondrial DNA during both the depletion process and in vitro reprogramming are discussed. It was possible to obtain bovine mesenchymal cells almost completely depleted of their mitochondrial DNA content (over 90%). However, the production of induced pluripotent stem cells from the transduction of both control and Rho0 bovine mesenchymal cells with human reprograming factors was not successful.
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INTRODUCTION
Mitochondria are maternally inherited organelles that play an essential role in cellular energetic metabolism, homeostasis, and death by generating most of the ATP necessary for energy-dependent biological processes through the oxidative phosphorylation (OXPHOS) pathway (Anderson et al., 1981) . These organelles exhibit their own genetic material, termed mitochondrial DNA (mtDNA), which is responsible for synthesizing 13 essential polypeptides for mitochondrial activity (Shadel and Clayton, 1997) . Each cell harbors between 1 and 10 mitochondria, with multiple copies of mtDNA, which are related to its capacity for energy production (Reynier et al., 2001) . Recently, mitochondria have been described to vary in number (St John et al., 2005) and morphology according to the cellular differentiation state; in pluripotent cells, mitochondria have swollen and poorly developed cristae (Sathananthan et al., 2002; Facucho-Oliveira and St John, 2009; Ramalho-Santos et al., 2009 ) that undergo changes during cellular differentiation (Facucho-Oliveira et al., 2007) .
Embryonic stem (ES) cells have few copies of oocyte-derived mtDNA (Shoubridge and Wai, 2007) because mtDNA replication does not occur during the early stages of development (Thundathil et al., 2005) , thus decreasing the number at each cell division (Shoubridge and Wai, 2007) . This mechanism might be an attempt to protect mitochondria and mtDNA from possible damage caused by reactive oxygen species (ROS) because ES cells do not seem to rely on OXPHOS for energy supply (Armstrong et al., 2010) . mtDNA replication proceeds and increases with cell differentiation. Therefore, mitochondria become mature and capable of oxidative metabolism only during and after the blastocyst stage (Facucho-Oliveira et al., 2007; reviewed by St John et al., 2010) .
A series of cellular changes and diseases are closely related to mutations in the number of mtDNA copies (King and Attardi, 1996; Scarpulla, 2008) . One way to mimic these changes in the number of mtDNA copies, in vitro, is mitochondrial depletion by exposing the cultured cells to ethidium bromide (EtBr), which inhibits mtDNA replication and, hence, decreases the number of mtDNA copies (Nass, 1970) . Interestingly, the morphology of these mitochondria-depleted cells greatly resembles that of pluripotent cells (Sathananthan et al., 2002; Facucho-Oliveira and St John, 2009; Ramalho-Santos et al., 2009 ) because they present mitochondria that are larger than those of normal cells but are fragmented and have spaced out and poorly developed cristae (Nass, 1970; Marusich et al., 1997) .
Herein, we aimed to study the mechanisms responsible for the control of mtDNA replication during mtDNA depletion mediated by EtBr in mesenchymal cells. The effect of EtBr during the induction of pluripotency in bovine cells, through the expression of exogenous transcription factors, was also studied. This article describes the development of a bovine Rho0 mesenchymal cell line and the depletion of the mtDNA during the introduction of reprogramming factors.
MATERIAL AND METHODS

Cell line establishment
A mesenchymal stem cell line was derived from a fragment of adipose tissue from the base of the tail of a female Nellore (Bos indicus). Briefly, the tissue was reduced to small pieces and incubated in 0.1% collagenase (Sigma, St. Louis, MO, USA) for 3 h at 38.5°C. After inactivation of the collagenase and centrifugation at 300 g for 5 min, the cell pellet was suspended in Iscove's modified Dulbecco's media (IMDM, Life Technologies, Grand Island, NY, USA), supplemented with 10% fetal calf serum (FCS, Gibco, Grand Island, NY, USA), 100 mg/mL pyruvate and 1% antibiotic, and cultured on 35 mm diameter dishes at 38.5°C in an atmosphere of 5% CO 2 and maximum humidity. Tests for the presence of mycoplasmal contamination were not performed. During the experiments, all the cells were cultured on 100 mm diameter dishes in IMDM supplemented with 10% FCS and 1% penicillin/streptomycin (Gibco, Grand Island, NY, USA). The cells were characterized as mesenchymal by immunostaining for surface antigens and by their in vitro differentiation into adipocytes, chondrocytes and osteocytes, following the procedures previously described by our group (Sampaio et al., 2015) .
mtDNA dynamics after EtBr treatment
Bovine mesenchymal stem cells were divided into two groups: a control group consisting of untreated cells and an EtBr group consisting of cells treated with ethidium bromide (EtBr, Sigma, St. Louis, MO, USA). These cells were cultured in vitro for 13 days under the conditions mentioned above. However, the medium was supplemented with EtBr (100 ηg/mL; EtBr group) and uridine (50 µg/mL; both groups), as suggested by King and Attardi (1996) .
In this experiment, 4.0 x 10 5 cells were seeded in 100-mm-diameter dishes. The cells were replated every 3 days, and samples were collected and analyzed at each passage. After 13 days of treatment, the cells were plated on 35 mm culture dishes and treated again for another 24 h with EtBr. On the 14 th day, the culture medium containing EtBr was removed from part of the cells for 12 days. From this point on, cells were categorized into three groups: EtBr-C: untreated group; EtBr-T: cells that were kept in culture with EtBr, and EtBr-R group: cells in the culture from which EtBr was removed. During this period, samples were collected at 0, 3, 6, 12, and 24 h and 2, 3, 7, and 12 days to evaluate the mtDNA copy number. Furthermore, the effect of EtBr on cell morphology was evaluated by optical microscopy at each passage.
Determination of the mtDNA copy number
The mtDNA copy number was estimated at each cell passage, as previously described (Nicklas et al., 2004) . Briefly, the samples were subjected to total DNA extraction based on the NaCl method (adapted from Miller et al., 1988) The extracted DNA was quantified by spectrophotometry (NanoDrop 2000, Thermo Scientific, Waltham, MA, USA) and frozen at -80°C. mtDNA quantification was then performed on a real-time PCR thermocycler (Applied Biosystems, 7500 Fast Real Time PCR System, Foster City, CA, USA) using TaqMan ® system Assays (Applied Biosystems, Foster City, CA, USA) following the manufacturer instructions. The samples were analyzed in duplicate using the endogenous beta actin gene (ACTB) as a control and primers listed in Table 1 . Table 1 . Primers used for relative quantification of the target gene (mtDNA) and the endogenous control (ACTB).
Semi-quantitative gene expression analysis of depleted cells
Cell samples were pelleted by centrifugation and stored at -80°C. Total RNA was extracted from the samples using TRIzol ® reagent (Life Technologies, Grand Island, NY, USA) according to manufacturer recommendations. The extracted RNA was subjected to reverse transcription using the High Capacity RNA-to-cDNA Kit (Applied Biosystems, Foster City, CA, USA) following the manufacturer instructions. Quantification of gene expression was performed on the real-time PCR thermocycler. The relative quantification of the target genes (BAX, BCL-2, and TFAM; Table 2 ) and the endogenous control (ACTB) was performed using the SYBR ® Green PCR system (Applied Biosystems, Foster City, CA, USA) and 0.2 mM of each oligonucleotide primer in a 20-μL reaction, using specific primers ( Table 2 ). The reaction was initiated by incubation at 50°C for 2 min, followed by denaturation at 95°C for 10 min, and 45 cycles of 95°C for 15 s and 60°C for 1 min. Each sample was evaluated in duplicate for all genes in all reactions. 
PCR data analysis
To analyze the gene expression, we generated a standard curve using five serial dilutions (1:1) of the control sample. From the slope of the curve (Slope) and the "Ct" values, we calculated the amplification efficiency {E = 10
} individually for each gene studied, as described by Livak and Schmittgen (2001) . Mathematical procedures were then used to determine the expression level of the target genes relative to the endogenous gene.
Pluripotency induction
the lipofection of 293FT cells (Invitrogen, Carlsbad, CA, USA) with the lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) and introduced to the bovine mesenchymal cells' genomes (both control and EtBr groups). Bovine mesenchymal cells were plated the day before at a concentration of 10 5 cells per well in 6-well plates with 50 μL the viral concentrate and 8 μg/mL polybrene (hexadimethrine bromide, Sigma, St. Louis, MO, USA) in the medium, which was refreshed after every 12-16 h incubation. At 5-or 6-days-post-transduction, the cells were transferred to MEFs (murine embryonic fibroblasts) for a minimum of 14 days. Cells from the EtBr group had EtBr and uridine added to the medium.
The cell cultures were maintained in vitro for a minimum of 30 days and were collected at the specified time points for mtDNA analysis.
Statistical analysis
All statistical analyses were performed using SAS System (V9.2; SAS Institute, Inc., Cary, NC). Data were analyzed using analysis of variance (ANOVA) followed by the Student t-test, if necessary.
RESULTS
Cell culture behavior and mtDNA copy number during the depletion and repletion processes
In an attempt to obtain Rho0 cells, we exposed bovine mesenchymal cells to EtBr. After 13 days of treatment with EtBr, the mtDNA quantification results showed a depletion by approximately 90% of the original mtDNA content compared with the control group (P = 0.0459). Analysis at different time points during the EtBr treatment (D4, D7, D10, and D13); on day 4 itself, the content of mtDNA had dropped to less than 10% of its original amount (Figure 1) .
After 13 days of depletion, EtBr was removed from the culture medium, and the cells were cultured for an additional 2 days during which samples were collected. Although a recovery of the mtDNA copy number was expected, the number of copies remained similar to that of cells kept in culture with EtBr (Figure 2 ). There was a significant difference in the number of copies (P < 0.05) between the untreated group (EtBr-C) and the other groups. However, there were no differences (P < 0.05) between the EtBr-T and EtBr-R groups. Thus, the cells were then kept in culture without EtBr for an additional 10 days, but the repletion of the mtDNA copy number could not be detected (Figure 2) . 
Pluripotency induction
Pluripotency factors were introduced to bovine mesenchymal cells from the control and EtBr groups using a STEMCCA lentivirus vector. After day 20, the transfected control cells presented a few structures that resembled induced pluripotent stem (iPS) cell colonies (Figure 3 ), but these formations were not maintained and the cells died shortly after. The depleted cells did not result in colony formation or other reprogramming characteristics, such as a round shape, large nuclei, or a small amount of cytoplasm. Despite the distinct decrease observed in the mtDNA copy number of the control cells after transduction (887.71 ± 127.27 and 503.47 ± 170.33 copies per cell, respectively, for the non-transduced control and transduced control cells), which suggests an effect of cellular reprogramming on the mtDNA levels, there was no significant difference among the cells from the control group. However, both cells treated with EtBr did differ from the cells of the control group (P < 0.05) after the introduction of the pluripotency factors (Figure 4 ).
Gene expression
Considering the mitochondrial changes resulting from the depletion process and the role of mitochondria in apoptosis (Champelovier et al., 2013) , the cells in this experiment were examined for the ratio of BAX/BCL-2 (Figure 5 ), which is decisive for cell fate (Nagata, 1997) , and the expression of TFAM (Figure 6 ), a gene that represents the number of mtDNA copies in a cell (Schauen et al., 2006) .
Regarding the depletion experiment, despite the decrease in mtDNA copy number, no differences in the expression levels of the target genes were observed. The values found for TFAM expression for treated and untreated cells were 1.12 ± 0.21 and 0.80 ± 0.13, respectively. However, an increase in the BAX/BCL-2 ratio was found in cells containing less mtDNA (1.06 ± 0.34 and 0.79 ± 0.29, respectively, for depleted and untreated cells).
In the repletion experiment, the BAX/BCL-2 ratio increased in the cells from both the EtBr-T and EtBr-R groups compared with the cells from the control group (1.01 ± 0.33, 1.76 ± 0.44, and 1.66 ± 0.43, respectively, for untreated cells, depleted cells, and depleted cells after the removal of EtBr). Again, however, no difference among the groups was found regarding the expression of TFAM (0.56 ± 0.15, 0.28 ± 0.11, and 0.53 ± 0.13, respectively, for depleted cells, depleted cells after the removal of EtBr, and control cells). Regarding the pluripotency induction experiment, there was no difference between the groups for all the target genes studied. The values found for TFAM expression were 0.69 ± 0.12, 1.00 ± 0.13, 0.52 ± 0.14, and 1.16 ± 0.12, respectively, for untreated cells, untreated cells transfected with pluripotency factors, depleted cells, and depleted cells transfected with pluripotency factors. However, the values found for the BAX/BCL-2 ratio were 1.15 ± 0.35, 1.51 ± 0.41, 1.55 ± 0.41, and 1.52 ± 0.41, respectively, for untreated cells, untreated cells transfected with pluripotency factors, depleted cells, and depleted cells transfected with pluripotency factors. Figure 5 . BAX/BCL-2 expression during mtDNA depletion. In (A) (depletion condition), when the cells were treated with EtBr for 48 hours no increase on BAX/BCL-2 ratio was observed, probably due to the shorter treatment period. In (B), cells treated with EtBr for 13 days showed an increased BAX/BCL-2 ratio. This was expected because apoptosis is closely related to the loss of mitochondrial membrane potential, and it is in agreement with the decreased cell proliferation observed after EtBr treatment. This increase was not observed in (C) during Pluripotency induction. 
DISCUSSION
mtDNA depletion caused by treatment with EtBr has previously been described in the literature in rodent fibroblasts and liver cells (Nass, 1970) and in various human cells types (King and Attardi, 1996; Marusich et al., 1997; Seidel-Rogol and Shadel, 2002; Armand et al., 2004; Jeng et al., 2008; Magda et al., 2008; Mineri et al., 2009 ). Herein, we described the production of bovine mesenchymal Rho0 cells after 13 days in culture with EtBr. A decrease of approximately 90% in the mtDNA copy number was observed in these cells, and this decrease was maintained even after 12 days of culture in medium without EtBr. This result differs from that observed in HeLa cells depleted for 6 days, which showed signs of mtDNA repletion when cultured without EtBr for 12 days (Seidel-Rogol and Shadel, 2002) . Depleted human 143B TK-cells also showed signs of mtDNA recovery when cultured for seven days without EtBr (Jeng et al., 2008) . Depletion was expected once mtDNA replication had been inhibited by treatment with EtBr, as this inhibition causes the initial number of mtDNA copies to be cut in half after each cellular division (Nass, 1970) . The depleted cells also presented lower proliferation rates compared with control cells, similar to what has been observed for different depleted cell types, including MOLT-4 (Armand et al., 2004) , A549 (Magda et al., 2008) , and 143BTK-and A549 (Mineri et al., 2009) (Jeng et al., 2008) , when compared to control cells (A), bovine EtBr depleted cells (B) did not show morphological changes.
The regulation of the mtDNA copy number of a cell is essential during development, and this process is modified in the production of iPS cells (St John, 2014) .
Furthermore, the mitochondria of pluripotent cells and cells depleted of mtDNA are similar in appearance (i.e., they are swollen and fragmented and have poorly developed cristae; Nass, 1970; Marusich et al., 1997; Armand et al., 2004) . Thus, we hypothesized that the use of depleted cells for pluripotency induction would assist the reprogramming process because these cells would already present certain mitochondrial aspects of undifferentiated cells. However, when cells from the EtBr-T and EtBr-C groups were transduced with human exogenous transcription factors, we did not observe the formation of round shaped colonies or any other iPS cell characteristics (Figure 3) .
Nevertheless, despite the absence of statistically significant differences when analyzing the mtDNA quantification data, we recognized that both groups of cells treated with EtBr (transduced or not transduced) and the transduced control group showed a decreased mtDNA copy number (Figure 4 ). This observation, due to the dedifferentiation factors, may be indicative of partial cellular reprogramming because a low mtDNA copy number is found in both embryonic stem cells and in iPS cells (Kelly et al., 2013) .
Recent studies have highlighted the importance of metabolic reprogramming in the production of iPS cells. This reprogramming is associated with the transition of cell energy production from oxidative phosphorylation to glycolysis, which is highly important for cells with extensive proliferative potential: decreased mitochondrial oxidative stress (reviewed by Son et al., 2013) protects the cells from possible damage by ROS (Armstrong et al., 2010) . iPS cells presented decreased levels of ATP compared with embryonic stem cells (ESCs), and while mtDNA depletion in pluripotent cells diminishes the mtDNA copy number, it does not decrease the amount of ATP, which suggests that oxidative phosphorylation is not the major source of energy for these cells (Kelly et al., 2013) .
Despite evidence supporting a straightforward relationship between TFAM and the mtDNA copy number (reviewed by St John et al., 2010) and the fact that a low mtDNA copy number corresponds to non-existent levels of TFAM in bovine embryos up to the morula stage (St John, 2014), we did not find differences in TFAM expression for depleted and control cells in any of the experiments.
However, we did find an increased BAX/BCL-2 ratio in the depleted cells during both depletion and repletion experiments. This result was expected because apoptosis is a genetically controlled process that is closely related to the loss of mitochondrial membrane potential (Champelovier et al., 2013) , and it is in agreement with the decreased cell proliferation that followed EtBr treatment. Moreover, there were no differences between the EtBr and control groups during pluripotent induction. This result may indicate that both transduction and treatment with EtBr lead to a reduction in the mtDNA copy number but are not sufficient to generate full reprogramming, either individually or in combination.
CONCLUSION
In this study, bovine mesenchymal cells depleted of more than 90% of their mtDNA content were obtained. To our knowledge, this is the first report of bovine Rho0 cells. The transduction of both the control and the Rho0 cells with human reprograming factors was not capable of producing bovine iPS cells. However, we were able to identify a change in the dynamics of mtDNA, which could be observed in the reduction of the mtDNA copy number in the transduced cells but was more intense when using depleted cells. Our results provide useful cues that may be important for future clinical applications. In summary, this work discusses the relationship between mitochondrial function and the cellular reprogramming process. However, further studies are needed to better understand these mechanisms.
